Indivior Pharmaceuticals (INDV) Change in Acquisitions & Divestments (2024 - 2026)

Indivior Pharmaceuticals' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments changed 0.0% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 104.0% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments climbed to $6.0 million in Q1 2026 per INDV's latest filing, from -$13.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $46.0 million in Q3 2024 and bottomed at -$88.0 million in Q4 2024.
• The 3-year median for Change in Acquisitions & Divestments is $6.0 million (2025), against an average of $777777.8.
• Biggest YoY gain for Change in Acquisitions & Divestments was 85.23% in 2025; the steepest drop was 93.48% in 2025.
• Year by year, Change in Acquisitions & Divestments stood at -$88.0 million in 2024, then soared by 85.23% to -$13.0 million in 2025, then surged by 146.15% to $6.0 million in 2026.
• Per Business Quant, the three latest INDV Change in Acquisitions & Divestments figures stand at $6.0 million (Q1 2026), -$13.0 million (Q4 2025), and $3.0 million (Q3 2025).